Michael S. Iskra - 27 May 2022 Form 4 Insider Report for QuidelOrtho Corp (QDEL)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	QDEL	Stock Options	Award	$0	+22,020	$0.000000	22,020	27 May 2022	Common Stock	22,020	$59.53	Direct	F1, F2
transaction	QDEL	Stock Options	Award	$0	+16,809	$0.000000	16,809	27 May 2022	Common Stock	16,809	$119.06	Direct	F1, F3
transaction	QDEL	Restricted Stock Units	Award	$0	+15,825	$0.000000	15,825	27 May 2022	Common Stock	15,825		Direct	F4, F5, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation, Ortho Clinical Diagnostics Holdings plc ("Ortho"), QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each Ortho stock option was converted into a Stock Option to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions), except as adjusted by the Business Combination Agreement.
F2	Vested in full.
F3	9,804 shares are vested in full; 7,005 shares will vest on July 1, 2022.
F4	Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock.
F5	Pursuant to the Business Combination Agreement, each Ortho restricted stock unit was converted into a restricted stock unit representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions), except as adjusted by the Business Combination Agreement.
F6	15,825 shares will vest on April 1, 2023.